£55.00
In stock
**Tesamorelin** is a synthetic peptide that mimics the body’s natural growth hormone–releasing hormone (GHRH). It is designed to stimulate the pituitary gland to produce and release more endogenous growth hormone (GH), which in turn increases levels of insulin-like growth factor 1 (IGF-1). Unlike direct growth hormone administration, Tesamorelin works upstream, encouraging the body to follow its own physiological pathways of hormone release. Clinically, Tesamorelin is best known for its approved use in reducing excess visceral abdominal fat in individuals with HIV-associated lipodystrophy. By increasing growth hormone output, it promotes lipolysis—the breakdown of fat—particularly in deeper abdominal fat stores rather than subcutaneous fat. This makes it distinct from many fat-loss agents, as it targets a more metabolically harmful type of fat linked to cardiovascular and metabolic risk. Beyond its medical use, Tesamorelin has gained attention for its potential effects on body composition, recovery, and overall metabolic function. Elevated growth hormone and IGF-1 levels can support lean muscle maintenance, improve recovery from training, and contribute to better sleep quality in some individuals. However, these effects are secondary to its primary mechanism and are still being explored outside of clinical indications. Tesamorelin is typically administered via subcutaneous injection, often once daily due to its relatively short half-life but sustained biological effects through GH pulsatility. Its action is more regulated compared to exogenous growth hormone, meaning it tends to produce a more natural pattern of hormone release, which may reduce the likelihood of some side effects associated with direct GH use. In terms of safety, Tesamorelin has been studied in human clinical trials and is generally well tolerated when used as prescribed. Common side effects can include mild injection site reactions, joint discomfort, or fluid retention. However, because it influences the endocrine system, it should be used with caution, particularly in individuals with conditions affected by growth hormone or IGF-1 levels. Overall, Tesamorelin sits at the intersection of metabolic health and performance optimization. It offers a targeted way to increase endogenous growth hormone, with proven clinical benefits for visceral fat reduction and broader potential implications for body composition and recovery.